Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule
about
National follow up of Haemophilus influenzae meningitisThe UK Hib vaccine experienceAntibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell diseaseCombined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisationAntibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.Hib vaccination in infants born prematurely.Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom.Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease.Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2).Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infantsPaediatrics--Part II.Conjugate vaccines and the carriage of Haemophilus influenzae type b.Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United KingdomNorthern region asplenia register--analysis of first two years.The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.Effect of beta propiolactone on specific antibody measurements by ELISA.Polymerase chain reaction-based strain characterization of noncapsulate Haemophilus influenzae.Antibody persistence after accelerated immunisation against Haemophilus influenzae type bDevelopment of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
P2860
Q33624182-7C001AE1-9711-44CE-B8D5-ED38664902BEQ34649094-E0F4A6FB-982F-498D-BD83-D81E5BD40951Q34799261-AE4D7198-626A-449D-9F6F-F4B79FD8BE5AQ34799955-3C10F752-05B1-4D33-AD94-580D65F89854Q35257876-B57DDE9C-7C3B-4A4A-8ACB-470A47F79B38Q35275707-B71E85C8-AA05-4DC1-89A1-0DDBD860F2AFQ35276278-586EBB3B-F239-4E69-BFC4-BFB006C40B7CQ35283739-2BAA9A8A-8E8C-4C25-986F-50BA1B1B0E39Q35287762-4D9FD5D9-EC22-4245-BCD5-B7649BF61E30Q36504293-56BFDADA-7E98-4E2A-84E8-4C4195AFB283Q36598037-345486D6-965C-4A9D-AF4C-D41751C7C50EQ36683294-CAE6A6DF-A6EB-4775-9AB2-2985ED26F115Q37062275-455C1992-166F-4E8C-9ECE-80D0D65FAB69Q37099250-467C07B8-2034-4B3A-8B96-BC56CD2940BDQ37238458-AECEF283-2477-473F-BBF2-DD00496036B9Q37504676-9170A7DA-89EC-4043-9501-7162ACD78EFAQ39612129-4217F0EC-0ADC-416D-BCEC-EDC71147B369Q40190951-C78C4C65-4E94-484E-966F-F9A39A1C85E7Q40371809-DA8C2FB1-A857-46D7-88CA-C300D2F12CDEQ47759487-63B04EBD-8D42-4656-A45B-4D64D7C85041
P2860
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Immunogenicity and safety of P ...... elerated immunisation schedule
@ast
Immunogenicity and safety of P ...... elerated immunisation schedule
@en
type
label
Immunogenicity and safety of P ...... elerated immunisation schedule
@ast
Immunogenicity and safety of P ...... elerated immunisation schedule
@en
prefLabel
Immunogenicity and safety of P ...... elerated immunisation schedule
@ast
Immunogenicity and safety of P ...... elerated immunisation schedule
@en
P2093
P2860
P356
P1476
Immunogenicity and safety of P ...... elerated immunisation schedule
@en
P2093
Griffiths H
Macfarlane JA
Mayon-White RT
P2860
P304
P356
10.1136/ADC.67.4.475
P407
P577
1992-04-01T00:00:00Z